Las Palmas de Gran Canaria, June 3, 2025. Hospiten Roca is launching a new Maternal-Fetal Medicine Unit, as part of the process of expanding the Gynecology and Obstetrics service promoted by its head, Dr. Carlos Blanco-Soler. This new unit will be under the supervision of Dr. Anna Erenbourg, a specialist with extensive experience in prenatal diagnosis. According to Dr. Blanco-Soler, "there are very few professionals with the training and experience of Dr. Erenbourg, so her incorporation represents an important added value for the healthcare services that Hospiten Roca makes available to mothers-to-be in the Canary Islands".
With the integration of Dr. Anna Erenbourg, Hospiten Roca will offer specialized pregnancy monitoring using state-of-the-art technology in fetal medicine and, in addition, key tests will be performed, such as prenatal screening in the first trimester and morphological ultrasound in the second trimester, as well as the detection of trisomies in maternal blood, ensuring a controlled and safe pregnancy.
Dr. Erenbourg says that, since the beginning of her professional career, the successive interest in fetal cardiology has been related to the real possibility of treating possible heart disease. "Seeing the development of the human being in its first moments is wonderful and accompanying families in the process is an experience that fills me immensely," she says.
"During the last three years of my international training, I had the opportunity to work at the University of New South Wales in Sydney, Australia, and at the Centre Hospitalier du Bordeaux, France," she says. In this regard, the specialist indicates that this experience has given her the possibility of learning about different pathologies and working with experts in fetal medicine and cardiology to "learn and improve" the techniques that allow her to identify them and appreciate their management in prestigious centers at an international level.
Among the professional challenges during her specialization in fetal echocardiography was learning the details that allow the fetal heart to be appreciated and valued. "A key aspect has been the opportunity to have professionals willing to share their knowledge and experience, teaching me the development of their skills. Moreover, considering that the incidence of fetal heart disease is around 0.8-1.2% of live newborns, it is essential to spend time in large and/or reference centers specialized in this specific type of pathology in order to acquire a complete and solid experience," he stresses.
Advances in fetal medicine to detect genetic disorders
Fetal medicine is the part of obstetrics devoted to estimating the risk of fetal chromosomal and genetic problems and assessing normal fetal anatomical development by gestational age. The identification of some of these problems during gestation is of vital importance to determine the possibility of treatment, the postnatal consequences and the most appropriate place for delivery and newborn care.
Regarding the main recent advances in fetal medicine, the doctor specialized in fetal echocardiography points out that, in recent decades, fetal medicine has been in continuous development. Thanks to technological advances and the subspecialization of professionals, she highlights that many pathologies can be detected in the 20th week of gestation and others in the 12-13th week. "The introduction of fetal DNA allows for a very effective screening of the genetic part, making it possible to offer prospective parents an early diagnosis of genetic disorders," he says.
In addition, the Hospiten specialist points out that the quality of ultrasound imaging has evolved, allowing "more precise and earlier" detection of fetal pathologies, and explains that the application of artificial intelligence could represent a new revolution, since it reduces human error and, in the not too distant future, could offer an even greater capacity for detecting pathologies.
"Our center has state-of-the-art ultrasound systems that allow for detailed morphological and cardiological assessment. In addition to the normal anatomical assessment of the fetal heart, these machines allow for functional assessment and, if necessary, to add a component related to cardiac functionality to the morphological study," he says. "A number of studies have shown that early detection improves the health outcome of the newborn, which also allows us to monitor the pathology over time, evaluate possible treatments and identify the possible need to deliver the baby in a specialized tertiary center," he adds.
With this latest addition, Hospiten reinforces its broad portfolio of services and highly prestigious specialists at the disposal of patients' health.
About Hospiten
Hospiten is an international healthcare network with more than 55 years of experience committed to providing the highest quality service, with 20 private medical-hospital centers in Spain, the Dominican Republic, Mexico, Jamaica and Panama, in addition to 175 outpatient medical centers, under the Clinic Assist brand. Founded by Dr. Pedro Luis Cobiella, it annually attends more than three million patients from all over the world and has a staff of more than 5,000 people, a number that will be reinforced in the Community of Madrid thanks to the construction of a general university hospital in Boadilla del Monte, which is expected to be completed in 2026.
MD Anderson Cancer Center Madrid - Hospiten is a subsidiary of the prestigious MD Anderson Cancer Center in Houston (Texas, USA). With more than 20 years of history in Spain, MD Anderson Madrid - Hospiten currently has a Phase I Clinical Trials Unit, more than 150 medical specialists trained in oncology, a total of 87 hospital beds and state-of-the-art technological equipment for the diagnosis and treatment of different types of cancer.
This article is an English translation generated with AI from the original Spanish content. While we review content for clarity, the information is provided for general informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for diagnosis or treatment.